A practical and efficient enantioselective synthesis of antiepileptic drug, (−)-Levetiracetam, has been described in �ve steps (33.0% overall yield) and high optical purity (99.0% ee), using Evans asymmetric strategy for -alkylation of carbonyl functionality as the key step. e simplicity of the experimental procedures and high stereochemical outcome make this method synthetically attractive for preparing the target compound on multigram scales.
Introduction
Epilepsy is a chronic neurological disorder that consists of repeated occurrences of spontaneous seizures. Levetiracetam, [(S)-a-ethyl-2-oxopyrrolidine acetamide], (Figure 1 ) has recently been approved as an add-on therapy for the treatment of refractory epilepsy [1] . e (S)-enantiomer of etiracetam (levetiracetam) has shown remarkable pharmacokinetic and pharmacological activity which has led to the quick approval of this antiepileptic drug by the FDA. Levetiracetam offers several advantages over traditional therapy, including twice-daily dosing, a wide margin of safety with no requirements for serum drug concentration monitoring and no interactions with other anticonvulsants, and less adverse effects than traditional treatments [2] [3] [4] .
Reported methods for the synthesis of levetiracetam typically involve chiral pool approaches starting from relevant enantiopure -amino acids [5] [6] [7] [8] , resolution of etiracetam or advanced racemic intermediates [5] [6] [7] [8] [9] [10] , asymmetric hydrogenation over Rh(I) or Ru(II) complexes [11, 12] , and deracemization of 2-bromobutyric acid using N-phenyl pantolactam as a chiral auxiliary [13] , proline catalyzed asymmetric -aminooxylation [14] .
e synthesis of 1 has been previously reported by S. P. Kotkar, A. Sudalai using proline-catalyzed -aminooxylation of n-butyraldehyde in eight steps and 29.7% overall yield 7 and to the best of our knowledge Evans type chiral auxiliary directed entioselective synthesis of (−)-Levetiracetam has not yet been reported. Chiral auxiliary derived asymmetricalkylation reactions have been identi�ed as general method for asymmetric carbon-carbon bond formation [15, 16] . In this connection, Evans asymmetric strategy is the most powerful synthetic method that has been widely employed in natural product synthesis [17] [18] [19] [20] [21] [22] [23] . Moreover, the Evans type auxiliaries are inexpensive, nontoxic, available in both enantiomeric forms, and already explored for large scale synthesis of pharmaceutical important molecule like "Ezetimibe" (marketed as Zetia or Ezetrol) [24] antihyper lipidemic drug and "Tapentadol" (trade name Nucynta, in India Zyntap) is a centrally acting analgesic [25] , and so forth.
In this paper, we report a practical and efficient enantio selective synthesis of levetiracetam, 1, in �ve steps with good overall yield using Evans type asymmetric -alkylation of compound 4. e retrosynthetic analysis of 1 is show in (Figure 2 ).
Experimental Section
All reagents and solvents employed were of commercial grade and were used as such, unless otherwise speci�ed. Reaction �asks were oven-dried at 200 ∘ C, �ame-dried, and �ushed with dry nitrogen prior to use. All moisture and airsensitive reactions were carried out under an atmosphere of dry nitrogen. TLC was performed on Kieselgel 60 F254 silica-coated aluminium plates (Merck) and visualized by UV light ( = 254 nm) or by spraying with a solution of KMnO 4 . Organic extracts were dried over anhydrous Na 2 SO 4 . Flash chromatography was performed using Kieselgel 60 brand silica gel (230-400 mesh). e melting points were determined in an open capillary tube using a Büchi B-540 melting point instrument and were uncorrected. e IR spectra were obtained on a Nicolet 380 FT-IR instrument (neat for liquids and as KBr pellets for solids). NMR spectra were recorded with a Varian 300 MHz Mercury plus Spectrometer at 300 MHz ( 1 H) and at 75 MHz ( 13 C). Chemical shis were given in ppm relative to trimethylsilane (TMS). Mass spectra were recorded on Waters quattro premier XE triple quadrupole spectrometer using either electron spray ionization (ESI) or atmospheric pressure chemical ionization (APCI) technique.
Preparation of (S)-3-(2-Chloroacetyl)-4-phenyloxazolidin-2-one (3).
A solution of chloroacetyl chloride (9.76 mL, 0.122 mol) in DCM (100.0 mL) was added dropwise to a solution of (S)-4-phenyloxazolidin-2-one, 2 (10.0 g, 0.61 mol), Et 3 N (35.0 mL, 0.244 mol) and DMAP (9.5 g, 4.0 mol) in DCM (150.0 mL) while maintaining temperature at 0-5 ∘ C. Aer 30 min additional chloroacetyl chloride was added (0.2 eq), and the mixture was gradually allowed to warm up to room temperature. Aer mixture was vigorously stirred for 1 h, silica gel (20.0 g) was added and the reaction mixture was concentrated in vacuo. e resultant product was loaded on to a silica gel �ash column. 
Preparation of (S)-3-(2-(2-Oxopyrrolidin-1-yl)acetyl)-4-phenyloxazolidin-2-one (4).

4(S)-3-((S)-2-(2-Oxopyrrolidin-1-yl)butanoyl)-4-phenyloxazolidin-2-one (5). A cooled (−78
∘ C) solution of (5.0 g, 0.017 mol) of 4 in 50.0 mL of dry tetrahydrofuran was added to a precooled (−78 ∘ C) solution of (26.0 mL, 0.026 mol) of 1 M sodium bis(trimethylsilyl)amide in toluene diluted with 60.0 mL of dry THF, keeping the temperature below −60 ∘ C. Aer 30 min at −78 ∘ C, a precooled solution of (3.24 g, 0.020 mol) of ethyl iodide in 40.0 mL of dry THF was added. Aer 2 h at −75 ∘ C, 5.0 mL of glacial acetic acid was added and the mixture warmed immediately to 30 ∘ C for 1 h. e solution was partitioned between methylene dichloride (200.0 mL) and dilute brine (100.0 mL). e aqueous phase was extracted with three 75.0 mL portions of methylene chloride. Combined organic extracts were washed with saturated NaHCO 3 (100.0 mL) and dried (MgSO 4 ), and concentrated. Chromatography on silica gel with 1 : 9 (ethyl acetate: methylene chloride) gave 5 (4.4 g, 81%) of product as a white solid. (6) . To a cold (0 ∘ C) solution of 5 (5.0 g, 0.015 mol) in THF (30.0 mL), 30% w/v H 2 O 2 (8.5 mL, 0.074 mol), and LiOH/H 2 O (1.13 g, 0.047 mol) were added sequentially and the mixture was stirred at this temperature for 7 h. A solution of Na 2 SO 3 (75.0 mL) was added, the �nal pH being about 9. is mixture was extracted with Methylene dichloride (150 mL), was then it discarded and the aqueous phase was made acidic (pH = 2-3) with 1 M HCl and subsequently extracted with AcOEt (150 mL). e combined AcOEt organic extracts were dried over Na 2 SO 4 and concentrated in vacuo. to give (S)-6 (2.3 g, 85%) as a white solid. 
Preparation of (S)-2-(2-Oxopyrrolidin-1-yl)butanoic Acid
Preparation of (S)-2-(2-Oxopyrrolidin-1-yl)butanemide (1, Levetiracetam).
To a cold (0 ∘ C) solution of acid (S)-6 (5.0 g, 0.292 mol) and Et 3 N (4.3 mL, 0.307 mol) in anhydrous THF (20 mL) was added ethylchloroformate (2.9 mL, 0.304 mol) and the mixture stirred at 0 ∘ C for 30 min. Ammonium hydroxide (25% w/v aqueous solution, 19.0 mL) was added and the reaction mixture was le to stir at room temperature for 12 h. Aer the addition of K 2 CO 3 (4.14 g, 30.0 mol), the mixture was �ltered and the volatile materials (solvent and Et 3 N) distilled off in vacuo. e solid residue was extracted with methylene dichloride (150 mL) and the combined organic extracts dried over Na 2 SO 4 and concentrated in vacuo recrystallization from acetone (100.0 mL) gave 1 
Results and Discussion
As shown in (Scheme 1), the synthesis of (−)-levetiracetam, e alkylation had indeed occurred from the least hindered face of the enolate delivering the required stereochemistry.
Study of Selectivity during Alkylation with respect to
Auxiliary and Size of Metal Ion. e discrepancy of stereoselectivity during -alkylation with respect to substitution of auxiliary and size of metal ion was studied. e enolate derived from 4a & 4b with NaHMDS was alkylated under same conditions with ethyl iodide and the results are summarized in (Table 1) .
(S)-phenyl substituted auxiliary showed higher diastereoselectivity (99% ee) as compared to (S)-benzyl auxiliary (<85% ee) with NaHMDS as the base, the diastereomeric ratios during alkylation were determined by chiral HPLC purity of �nal product (−)-Levetiracetam, 1. Whereas LiH-MDS provided similar results with 4a & 4b, but not as well as those with NaHMDS. Removal of the chiral auxiliary in compound 5 was carried out by LiOH/H 2 O 2 in THF to afford the corresponding acid 6 in 85% yield. is is particularly noteworthy in a way that the (S)-4-phenyloxazolidin-2-one could be recovered in 85% yield, aer a simple acid-base workup operation. Acid 6 on treatment with ethyl chloroformate and ammonium hydroxide produced (−)-Levetiracetam, 1, in 86% yield and 99.0% ee (determined by chiral HPLC analysis). e spectral data which were found to be in good agreement with reported values [26] .
Conclusion
In conclusion, a practical and efficient enantioselective synthesis of levetiracetam, 1, has been achieved successfully by employing Evans type asymmetric strategy. e merit of the mentioned approach is less number of steps (5 steps), improved overall yield (33.0%) and high enantioselectivity (99.0% ee). is sequence has also been applied to the preparation of the enantiomer of levetiracetam and brivaracetam, and so forth. e simplicity of the experimental procedures and high stereochemical outcome make this method synthetically attractive for preparing the target compound on multigram scales and industrial applications. See Supplementary Material available online at doi:10.1155/2013/176512, including copies of the 1 H, 13 C NMR, Mass, IR spectra of the new compounds.
